Seres Therapeutics (MCRB) Shares Issued (2014 - 2026)
Seres Therapeutics (MCRB) posted Shares Issued of $1.6 million for Q1 2026, up 46.14% sequentially from $1.1 million in Q4 2025, and up 231.73% YoY from $495252.0 in Q1 2025.
Seres Therapeutics (MCRB) Shares Issued (2014 - 2026) Analysis & Trends
Seres Therapeutics has reported Shares Issued for 13 years, with the latest figure at $1.6 million in Q1 2026.
- Quarterly Shares Issued rose 231.73% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 231.73% YoY) and the FY2025 annual result came in at $1.1 million, up 26.87% from the prior year.
- Shares Issued rose to $1.6 million in Q1 2026 per MCRB's latest filing, from $1.1 million in the prior quarter.
- Over five years, Shares Issued peaked at $19.3 million in Q2 2024 and troughed at $495252.0 in Q1 2025.
- A 5-year average of $9.1 million and a median of $9.0 million in 2024 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2025 and 2026: Shares Issued tumbled 97.42% in 2025, then jumped 231.73% in 2026.
- Over 5 years, Shares Issued stood at $14.9 million in 2022, then decreased by 0.64% to $14.8 million in 2023, then sank by 94.03% to $886123.0 in 2024, then grew by 26.87% to $1.1 million in 2025, then jumped by 46.14% to $1.6 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $1.6 million, $1.1 million, and $499771.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Seres Therapeutics | 43.87 Mn | 43.87 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.55 Mn |
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 499,771.00 |
| Sep 30, 2025 | 499,771.00 |
| Jun 30, 2025 | 499,042.00 |
| Jun 30, 2025 | 499,042.00 |
| Mar 31, 2025 | 495,252.00 |
| Mar 31, 2025 | 495,252.00 |
| Dec 31, 2024 | 886,123.00 |
| Dec 31, 2024 | 886,123.00 |
| Sep 30, 2024 | 19.12 Mn |
| Sep 30, 2024 | 19.12 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Jun 30, 2024 | 19.31 Mn |
| Mar 31, 2024 | 9.03 Mn |
| Mar 31, 2024 | 9.03 Mn |